Norton Rose Fulbright has advised Canadian cannabis company Khiron Life Sciences on the deal. Osborne Clarke has advised PharmaDrug, Inc.. Khiron Life Sciences acquired all shares...
Norton Rose Fulbright has advised Canadian cannabis company Khiron Life Sciences on the deal. Osborne Clarke has advised PharmaDrug, Inc.. Khiron Life Sciences acquired all shares...
You must be a Standard 1 Year member to access this content.